Valerie S. Morrison

Publications by Year

Research Areas

Gastrointestinal motility and disorders, Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Asthma and respiratory diseases

Most-Cited Works

• → Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis(2020)119 cited
• → In Vitro Pharmacological Characterization of Vilanterol, a Novel Long-Acting β2-Adrenoceptor Agonist with 24-Hour Duration of Action(2012)111 cited
• → Synthesis and Structure−Activity Relationships of Long-acting β₂Adrenergic Receptor Agonists Incorporating Metabolic Inactivation: An Antedrug Approach(2010)98 cited
• → CRACM/Orai ion channel expression and function in human lung mast cells(2012)77 cited
• → Synthesis and Structure−Activity Relationships of Long-acting β₂Adrenergic Receptor Agonists Incorporating Arylsulfonamide Groups(2009)45 cited
• The value of prescribed 'high-fibre' diets for the treatment of the irritable bowel syndrome.(1991)
• → The discovery of long-acting saligenin β2 adrenergic receptor agonists incorporating hydantoin or uracil rings(2011)16 cited
• → Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease(2021)10 cited
• → P112 <break /> Discovery of a Novel, High Affinity, Small Molecule αvβ6 Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis(2016)8 cited
• → Dietary fibre intake of irritable bowel patients prescribed a high fibre diet(1991)5 cited